BioNote, Inc. (KRX: 377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,720.00
+85.00 (1.83%)
Nov 15, 2024, 9:00 AM KST

BioNote Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
81,651-20,497307,798676,601528,22920,613
Depreciation & Amortization
8,1048,2066,4514,1061,8871,410
Loss (Gain) From Sale of Assets
-152.19-265.2-13,412-361,22511.45200.91
Asset Writedown & Restructuring Costs
-8,409----
Loss (Gain) From Sale of Investments
2,7455,0005,150-15,047-544.38-15,645
Loss (Gain) on Equity Investments
28,32483,791-77,260--142,571-
Stock-Based Compensation
39.97-1,6371,985348.06-
Provision & Write-off of Bad Debts
-5,146-2,845-3,5966,827470.16-180.02
Other Operating Activities
-77,880-82,440-4,08934,137172,5264,158
Change in Accounts Receivable
4,167855.5773,437220,048-305,480-1,706
Change in Inventory
10,409-436.63-33,543-9,826-48,141158.9
Change in Accounts Payable
-275.62221.23-4,573-22,14027,513469.16
Change in Other Net Operating Assets
-1,434-4,193-8,9011,9265,679372.43
Operating Cash Flow
50,550-4,194249,100537,392239,9269,851
Operating Cash Flow Growth
11.16%--53.65%123.98%2335.49%-
Capital Expenditures
-7,620-3,963-42,266-51,425-26,698-1,518
Sale of Property, Plant & Equipment
406.7794.3649,399174.4378.08-
Cash Acquisitions
----6,266--
Sale (Purchase) of Intangibles
-65.86-579.33-217.44-118.58-23.59-10.16
Investment in Securities
197,563-477,108-37,446-133,747-84,749-32,374
Other Investing Activities
00---10
Investing Cash Flow
190,283-481,555-30,530-191,383-111,393-33,893
Short-Term Debt Issued
-150,000---11,600
Long-Term Debt Issued
-10.550---
Total Debt Issued
150,011150,01150--11,600
Short-Term Debt Repaid
--150,000---12,000-21,600
Long-Term Debt Repaid
--836-415.58-216.76-79.83-43.51
Total Debt Repaid
-151,094-150,836-415.58-216.76-12,080-21,644
Net Debt Issued (Repaid)
-1,084-825.5-365.58-216.76-12,080-10,044
Issuance of Common Stock
374.96843.6673,280--36,795
Dividends Paid
-20,411-49,919-49,959-49,959--
Other Financing Activities
---0-420415-
Financing Cash Flow
-21,120-49,90122,955-50,596-11,66526,752
Foreign Exchange Rate Adjustments
19,6991,97820,930118.56-364.69-75.65
Net Cash Flow
239,413-533,672262,455295,532116,5042,634
Free Cash Flow
42,930-8,156206,834485,966213,2288,333
Free Cash Flow Growth
248.08%--57.44%127.91%2458.84%-
Free Cash Flow Margin
45.15%-9.05%43.12%78.09%33.77%20.81%
Free Cash Flow Per Share
420.19-79.882193.655186.942279.1598.94
Cash Interest Paid
676.15602.8284.4444.25165.72468.26
Cash Income Tax Paid
6,81840,454157,006171,252993.03670.58
Levered Free Cash Flow
20,777-18,697129,964399,410150,205-
Unlevered Free Cash Flow
21,199-18,321130,017399,438150,313-
Change in Net Working Capital
-11,750-7,49520,219-151,924173,970-
Source: S&P Capital IQ. Standard template. Financial Sources.